Home
About
Overview
Management Team
Board of Directors
Pipeline
Overview
Mechanism of Action
Clinical Trials
For Patients/Physicians
Overview
Resources
Lupus Nephritis (LN)
Investors & Media
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Careers
Contact
All SEC Filings
Investors & Media
Investors & Media
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filing Type:
View All
40-F
40-F/A
40FR12B
40FR12B/A
6-K
CERTNAS
D
EFFECT
F-10
F-10/A
F-X
FWP
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SUPPL
Year:
View All
2018
2017
2016
2015
2014
Date
Form
Description
PDF
XBRL
Pages
04/06/18
SUPPL
Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers
78
03/29/18
EFFECT
Notice of Effectiveness
1
03/26/18
F-10/A
Registration statement for securities of certain Canadian issuers under the Securities Act of 1933
Documents
EX-5.1
58
03/15/18
40-F
Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4
Documents
EX-99.1
EX-99.2
EX-99.3
EX-99.4
EX-99.5
EX-99.6
113
03/15/18
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
9
02/23/18
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
02/13/18
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/09/18
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
01/04/18
F-X
For appointment of agent for service of process by issuers registering securities
2
01/04/18
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
EX-99.1
5
1
2
3
4
5
6
7
8
9
10